Showing results (11-20 of 61) with videos related to
Sort By:
Pageof 7
Cancer Research|June 17, 2006
Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patientsKazuo Koyanagi, Takuji Mori, Steven J O'Day, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapyMasaru Shinozaki, Steven J O'Day, Minoru Kitago, et al.Journal of the National Cancer Institute|January 22, 2004
Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanomaBret Taback, Steven J O'Day, Peter D Boasberg, et al.Clinical Chemistry|February 24, 2009
mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beadsMinoru Kitago, Kazuo Koyanagi, Takeshi Nakamura, et al.Cancer|October 31, 2009
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanomaEvan M Hersh, Steven J O'Day, Antoni Ribas, et al.Investigational New Drugs|February 19, 2011
Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcomaSteven J O'Day, Anna C Pavlick, Mark R Albertini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on Cancer stage II melanoma patients receiving adjuvant polyvalent vaccineL Andrew DiFronzo, Rishab K Gupta, Richard Essner, et al.Oncology|May 22, 2003
Biochemotherapy for metastatic melanoma with limited central nervous system involvementPeter D Boasberg, Steven J O'Day, Tim S Kristedja, et al.Clinical Chemistry|April 9, 2005
Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patientsKazuo Koyanagi, Christine Kuo, Taku Nakagawa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanomaJeffrey Weber, John A Thompson, Omid Hamid, et al.Pageof 7